EX-23.1 7 a2019-10kxexhibit231co.htm EX-23.1
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Cumberland Pharmaceuticals Inc.
Nashville, Tennessee
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-221402) and Form S-8 (No. 333-164376) of Cumberland Pharmaceuticals Inc. of our report dated March 20, 2020, relating to the consolidated financial statements and financial statement schedule which appears in this Form 10-K.
/s/ BDO USA, LLP
Nashville, Tennessee
March 20, 2020